SunLink Health Systems, Inc. reported earnings results for the second quarter and six months ended December 31, 2023. For the second quarter, the company reported sales was USD 8.51 million compared to USD 10.64 million a year ago. Net loss was USD 3.08 million compared to net income of USD 1.95 million a year ago. Basic loss per share from continuing operations was USD 0.06 compared to basic earnings per share from continuing operations of USD 0.32 a year ago. Diluted loss per share from continuing operations was USD 0.06 compared to diluted earnings per share from continuing operations of USD 0.32 a year ago. Basic loss per share was USD 0.44 compared to basic earnings per share of USD 0.28 a year ago. Diluted loss per share was USD 0.44 compared to diluted earnings per share of USD 0.28 a year ago.
For the six months, sales was USD 17.07 million compared to USD 18.09 million a year ago. Net loss was USD 4.42 million compared to net income of USD 0.393 million a year ago. Basic loss per share from continuing operations was USD 0.12 compared to basic earnings per share from continuing operations of USD 0.24 a year ago. Diluted loss per share from continuing operations was USD 0.12 compared to diluted earnings per share from continuing operations of USD 0.24 a year ago. Basic loss per share was USD 0.63 compared to basic earnings per share of USD 0.06 a year ago. Diluted loss per share was USD 0.63 compared to diluted earnings per share of USD 0.06 a year ago.